Cantwell, Grassley Want New Enforcement Authority for FTC to Fight Unfair Drug Pricing Practices and Provide More Transparency
U.S. Senators Maria Cantwell (D-Wash.), Chair of the Committee on Commerce, Science, and Transportation, and Senator Chuck Grassley (R-Iowa), Ranking Member of the Judiciary Committee, introduced legislation today that would empower the Federal Trade Commission (FTC) to increase drug pricing transparency and hold Pharmacy Benefit Managers (PBMs) accountable for unfair and deceptive practices that drive up the costs of prescription drugs at the expense of consumers.